Clinical Trial

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

Recruiting
View on ClinicalTrials.gov →
Summary
This trial is designed to evaluate whether low-dose colchicine, in addition to standard treatment recommended by guidelines, further reduces the risk of major adverse cardiovascular events in patients with acute coronary syndromes (ACS) through a prospective, randomized, double-blind, placebo-controlled clinical trial.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-11; most recent amendment 2024-10-27.
Status change: Not Yet Recruiting → Recruiting 2024-10-27
Trial Details
NCT Number NCT06215989
Lead Sponsor Beijing Anzhen Hospital
Conditions Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction, Non ST Segment Elevation Myocardial Infarction, Colchicine
Enrollment 6,574 participants
Start Date 2024-09-02
Primary Completion 2027-02 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2024-10-30